Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Balshi

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Multiple Sclerosis and Related Disorders|January 5, 2024
Clinical course of multiple sclerosis with comorbid endometriosis: A matched cohort studyAlexandra Balshi, Nova Manning, John Dempsey, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 12, 2023
High CD4+:CD8+ ratios with herpes zoster infections in patients with multiple sclerosis on dimethyl fumarateAlexandra Balshi, Emma Saart, Sarbesh Pandeya, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 26, 2025
Malignant melanoma and multiple sclerosis therapies: A disproportionality analysis of the FDA adverse event reporting systemAlexandra Balshi, John P Dempsey, Nova Manning, et al.
Multiple Sclerosis and Related Disorders|July 19, 2024
Worsening of lymphopenia in patients with multiple sclerosis when switched from dimethyl fumarate to diroximel fumarateJohn Patrick Dempsey, Lisa Wu, Alexandra Balshi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 8, 2020
Pilot randomized active-placebo-controlled trial of low-dose ketamine for the treatment of multiple sclerosis-related fatigueKathryn C Fitzgerald, Bridget Morris, Aurash Soroosh, et al.
Multiple Sclerosis and Related Disorders|September 17, 2024
Multiple sclerosis treatment underutilization predicts high risk for obstructive sleep apnea in patients with multiple sclerosisJohn Patrick Dempsey, Alexandra Balshi, Andrew Bouley, et al.
Frontiers in Neurology|December 11, 2023
Prevalence of non-neurological autoantibodies and related comorbidities in stiff person spectrum disordersAlexandra Balshi, Elena Taylor, Yishang Huang, et al.
Journal of Neurology|November 25, 2025
Motherhood and diagnostic delay among women with multiple sclerosisAlexandra Balshi, John P Dempsey, Sachin Kumbar, et al.
Multiple Sclerosis and Related Disorders|May 29, 2025
Clinical characteristics associated with multiple sclerosis fatigue severityAlexandra Balshi, John P Dempsey, Nova Manning, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 19, 2025
Finite-course ocrelizumab in relapsing multiple sclerosis: Results of two prospective open-label trials with matched controlsAndrea Salazar-Camelo, Lauren Vega, Yasser Fadlallah, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Multiple Sclerosis and Related Disorders|January 5, 2024
Clinical course of multiple sclerosis with comorbid endometriosis: A matched cohort studyAlexandra Balshi, Nova Manning, John Dempsey, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 12, 2023
High CD4+:CD8+ ratios with herpes zoster infections in patients with multiple sclerosis on dimethyl fumarateAlexandra Balshi, Emma Saart, Sarbesh Pandeya, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 26, 2025
Malignant melanoma and multiple sclerosis therapies: A disproportionality analysis of the FDA adverse event reporting systemAlexandra Balshi, John P Dempsey, Nova Manning, et al.
Multiple Sclerosis and Related Disorders|July 19, 2024
Worsening of lymphopenia in patients with multiple sclerosis when switched from dimethyl fumarate to diroximel fumarateJohn Patrick Dempsey, Lisa Wu, Alexandra Balshi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 8, 2020
Pilot randomized active-placebo-controlled trial of low-dose ketamine for the treatment of multiple sclerosis-related fatigueKathryn C Fitzgerald, Bridget Morris, Aurash Soroosh, et al.
Multiple Sclerosis and Related Disorders|September 17, 2024
Multiple sclerosis treatment underutilization predicts high risk for obstructive sleep apnea in patients with multiple sclerosisJohn Patrick Dempsey, Alexandra Balshi, Andrew Bouley, et al.
Frontiers in Neurology|December 11, 2023
Prevalence of non-neurological autoantibodies and related comorbidities in stiff person spectrum disordersAlexandra Balshi, Elena Taylor, Yishang Huang, et al.
Journal of Neurology|November 25, 2025
Motherhood and diagnostic delay among women with multiple sclerosisAlexandra Balshi, John P Dempsey, Sachin Kumbar, et al.
Multiple Sclerosis and Related Disorders|May 29, 2025
Clinical characteristics associated with multiple sclerosis fatigue severityAlexandra Balshi, John P Dempsey, Nova Manning, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 19, 2025
Finite-course ocrelizumab in relapsing multiple sclerosis: Results of two prospective open-label trials with matched controlsAndrea Salazar-Camelo, Lauren Vega, Yasser Fadlallah, et al.
Pageof 4